Validation of proprotein convertase furin as potential target in rhabdomyosarcoma
Open access
Author
Date
2012Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-007618487Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETHSubject
RHABDOMYOSARKOME (PATHOLOGIE); THERAPIEN + THERAPEUTIK (MEDIZIN); BAKTERIOPHAGEN (VIROLOGIE); PROTEINANALYTIK + PEPTIDANALYTIK (BIOCHEMIE); PROTEINE, POLYPEPTIDE, ENZYME, ENZYMINHIBITOREN, PEPTIDE (PHARMAZIE); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); RHABDOMYOSARCOMATA (PATHOLOGY); THERAPIES + THERAPEUTICS (MEDICINE); BACTERIOPHAGES (VIROLOGY); PROTEIN ANALYSIS + PEPTIDE ANALYSIS (BIOCHEMISTRY); PROTEINS, POLYPEPTIDES, ENZYMES, ENZYME INHIBITORS, PEPTIDES (PHARMACY); TARGETED DRUGS (PHARMACOLOGY)Organisational unit
02020 - Dep. Chemie und Angewandte Biowiss. / Dep. of Chemistry and Applied Biosc.03688 - Schibli, Roger / Schibli, Roger
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 20677, 2012.More
Show all metadata
ETH Bibliography
yes
Altmetrics